Christie & Co: Paul Graham

Paul Graham

Business property advisor Christie & Co has promoted Paul Graham to the position of managing director, medical, tasked with overseeing the entirety of Christie & Co’s medical services offering, from brokerage to valuation, including sectors such as dentistry, pharmacy, general practice and veterinary services.

Graham joined Christie & Co’s corporate medical team in 2014. He was made director in 2017 and was later appointed as head of dental in the UK, leading a team of agents and advisors across the country, spearheading the brokerage side of the dental business.

The role was previously held by Simon Hughes, who led the company’s expansion into pharmacy, dentistry, GP surgeries and other ‘white coat’ sectors in 2013. Hughes now moves into the role of commercial director, where he will help develop and improve key business areas.

Darren Bond, global managing director at Christie & Co, said: “Our medical team has been market-leading with its dental and pharmacy activity in recent years, and I have every confidence that the business will continue to increase its market share under Paul’s leadership. I’d also like to thank Simon for establishing such an incredible team over the last 10 years and I look forward to working together with him in his new strategic role.”

Graham commented: “I have had the distinct privilege of working closely with Simon, witnessing first-hand the remarkable impact he has made in our medical sector, and I’m deeply grateful for his contributions and stewardship. Our team’s success has been immense and is a testament to the amazing efforts and expertise of the colleagues within; for this, I am incredibly grateful.

“My commitment to our business spans across dental, pharmacy and medical valuations, and, as I embark on this new chapter, I am energised to drive continued development and growth.

Join our mailing list

Stay up to date with all our events, awards and publications.

Information you provide us with will be kept private at all times, and will be used for communication and research purpose only.